The short version
- A Cochrane review of three high-quality trials found that after 24 to 40 months of omega-3 supplementation the difference from placebo on the Mini-Mental State Examination across 3,221 cognitively healthy older adults was -0.07 points (95% CI -0.25 to 0.10).
- In AREDS2, 3,501 participants with a mean age of 72.7 were tested over five years and the yearly change in composite cognitive score differed by -0.03 between those taking 1g of long-chain omega-3s and those not (99% CI -0.20 to 0.13, P = 0.63).
- A meta-analysis of 24 randomised trials found no improvement in any cognitive measure overall, and an improvement in short-term memory only in participants with low omega-3 status.
- The MIDAS trial gave 900mg of DHA daily for 24 weeks to 485 adults aged 55 and over who were already scoring at least one standard deviation below younger adults on logical memory, and paired-associate learning errors fell by 1.63 relative to placebo.
- In MIDAS, plasma DHA doubled and the increase correlated with the improvement in learning scores, which is the pattern you expect from correcting a shortfall rather than from enhancement.
The brain is built substantially out of fat, and DHA is one of the fats it is built out of. That is true, it is on a thousand product pages, and it is why people assume the supplement question is settled. It is not settled, and the way it fails is genuinely interesting: the trials that found something and the trials that found nothing were studying different people.
Nothing, in cognitively healthy older adults
The Cochrane review asked the cleanest version of the question. It included randomised trials giving omega-3 for at least six months to people aged 60 and over who were free of dementia and cognitive impairment at baseline. Three trials qualified, with cognitive data on 4,080 people at the start and 3,536 at final follow-up.
On the Mini-Mental State Examination, after 24 or 40 months of supplementation, the difference between omega-3 and placebo across 3,221 participants was -0.07 points (95% CI -0.25 to 0.10). In two studies covering 1,043 people, word learning, digit span and verbal fluency showed no benefit either. The reviewers rated all three trials high quality and adherence above 90%. The main side effect was mild gastrointestinal upset.
Nothing again, in 3,501 people over five years
AREDS2 was designed to test supplements for macular degeneration, and it carried a cognitive study alongside. Of 4,203 participants, 3,501 completed cognitive testing by telephone at baseline and every two years for five years, on 1g a day of long-chain omega-3s or not, in a factorial design.
Mean age 72.7. Yearly change in the composite cognitive score was -0.19 in the omega-3 group and -0.18 in the group not receiving it — a difference of -0.03 (99% CI -0.20 to 0.13, P = 0.63). Both groups declined at the same rate, for half a decade, in three and a half thousand people.
The one place a signal appears
A 2015 meta-analysis at King's College London pooled 24 randomised trials of omega-3 and cognition across three populations: healthy adults, typically developing school-aged children, and children with ADHD or related neurodevelopmental disorders. In the whole sample, and in each of those subgroups, supplementation did not improve any measure of cognitive performance.
With one exception. In participants with low omega-3 status, supplementation improved short-term memory. The authors' conclusion is a sentence a supplement company would not write: claims of cognitive benefit should be narrowed.
That is the pattern, and once you see it the rest of the literature reorganises around it. This is a nutrient. Nutrients correct deficits. Correcting a deficit in someone who has one is a real effect; giving more of it to someone who is already replete is not the same intervention, and it should not be expected to produce the same result.
The best positive trial, read carefully
The strongest positive result in healthy adults is MIDAS, and it fits the pattern rather than breaking it. It randomised 485 adults aged 55 and over to 900mg a day of DHA or placebo for 24 weeks. Crucially, entry required a Mini-Mental score above 26 and a Logical Memory score at least one standard deviation below younger adults — in other words, people already measurably declining.
Paired-associate learning errors fell relative to placebo (difference -1.63, 95% CI -3.1 to -0.14, P = 0.03), and immediate and delayed verbal recognition memory improved. Working memory and executive function did not move. Plasma DHA doubled, and the increase correlated with the improvement in learning scores.
Two honest notes. The lead author worked for the company that made the DHA. And the correlation between plasma DHA and improvement is the part that supports the whole argument of this article: the people who went up were the people whose blood levels went up.
So what should you take from this?
If you eat oily fish a couple of times a week, the trial evidence says a capsule is unlikely to change your cognition, and two very large studies in older adults say it does not slow decline. If you eat none, you are in the group where the only positive signal in the pooled data appeared, and a supplement is a reasonable, cheap correction — for the deficit, not for your concentration.
This is the same logic that runs through the supplements and ADHD literature, where omega-3 shows a small effect that is easy to overstate, and the same logic behind ferritin and B12: test or estimate first, replace if short, do not expect replacement to act as enhancement.
What we'd actually tell you
Count your fish. Two portions of salmon, mackerel, sardines or herring a week puts most people where the trials say supplementation adds nothing. If you genuinely eat none — no fish, no seafood, and no algae oil — then take a capsule for the nutritional gap and judge it as nutrition rather than as a focus product.
We do not sell fish oil, so this costs us nothing to say: if your complaint is fog, effortful thinking and losing the thread, the omega-3 aisle is not where that gets solved. Sleep debt and a basic blood panel are ahead of it in the queue, and both are more likely to give you an answer.
Good questions
Does fish oil improve memory in healthy people?
No, on the available trials. A Cochrane review of three trials in cognitively healthy older adults found a difference of -0.07 points on the Mini-Mental State Examination, and AREDS2 found identical five-year decline in 3,501 people. The one pooled positive was in participants with low omega-3 status, where short-term memory improved.
How do I know if my omega-3 status is low?
Count your fish before you count anything else. Two portions a week of salmon, mackerel, sardines or herring puts most people in the range where the trials say supplementing adds nothing. If you eat no fish or seafood at all, you are plausibly in the group where the only measured cognitive signal appeared.
How much DHA is in the trials that worked?
MIDAS used 900mg of DHA a day for 24 weeks in adults aged 55 and over who were already measurably declining. AREDS2 used 1g of combined long-chain omega-3s for five years and found nothing in a healthier population. Dose is not the variable that separates the positive trials from the null ones.
Will omega-3 stop my memory getting worse as I age?
The two largest tests say no. Cochrane found no benefit on cognitive function in healthy people aged 60 and over across trials running up to 40 months, and AREDS2 found both groups declined at the same rate over five years. Nobody has shown an effect on incident dementia either way.
Is fish oil worth taking at all then?
As nutrition, often yes, especially if you eat no fish. As a focus product, the evidence does not support it. The distinction matters because it changes what you should expect and when you should stop. Judge a capsule filling a dietary gap on your diet, not on how sharp you feel this month.
Are there downsides to taking fish oil?
Mild gastrointestinal problems were the main side effect reported in the Cochrane trials, with minor adverse events in fewer than 15% of participants and no imbalance between groups. It is well tolerated. The realistic cost is money spent on the wrong problem while the actual cause of poor concentration goes uninvestigated.
Sources
- Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev, 2012. View study
- Chew EY, Clemons TE, Agrón E, Launer LJ, Grodstein F, Bernstein PS. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial. JAMA, 2015. View study
- Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis. J Psychopharmacol, 2015. View study
- Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement, 2010. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
